Clinical study of Unani Formulation in Tinea Corporis
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2024/06/068679
- Lead Sponsor
- ational Research Institute Of Unani Medicine For Skin Disorders
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1 Participants of any gender in age group of 18-60 years
2 Participants of Qub ?(Tinea Corporis) having circumscribed lesions with any of the following signs and symptoms on body and limbs:
a Presence of pruritus and burning
b Presence of scales
c Presence of central clearing
d Erythematous papules
3 Participants with Positive KOH (10%) Smear Microscopy of Skin Scrapping from the active lesion for Dermatophytic hyphae
Participants who are willing to participate and comply with the protocol and sign to IEC approved ICF.
The following patients will be excluded:
Age below 18 years and above 60 years
Patients with other form of tinea infection like tinea cruris (groin), tinea capitis (head), tinea pedis (foot), tinea mannum (hands), tinea unguium (nails), tinea barbae (beard), tinea faciei (face),etc.
Patient with other concomitant diseases like psoriasis & eczema
Patients who have received any topical antifungal therapy within last 2 weeks or oral antifungal therapy in the previous 4 weeks
Patients with known active pulmonary/ cardiovascular/ liver/ renal or neurological diseases
Known cases of Diabetes Mellitus or other immunocompromised disorders (HIV/ AIDS, etc.)/ Malignancies
Patients with long-term history of steroid, cytotoxic and immunosuppressive therapy
History of hypersensitivity to either itraconazole or any test drug
Pregnant or lactating women, and women desiring pregnancy
Participants not willing to give consent and to attend treatment schedule regularly
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method